Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Stevens-Johnson Syndrome | Case report

Amoxicillin/Clindamycin/Cotrimoxazole

Stevens-Johnson syndrome

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Kim I, et al. AN UNEXPECTED CAUSE OF STEVENS-JOHNSON SYNDROME. Annals of Allergy, Asthma and Immunology 131 (Suppl. 1): S120-S121 abstr. M078, No. 5, Nov 2023. Available from: URL: 10.1016/j.anai.2023.08.359 [abstact] Kim I, et al. AN UNEXPECTED CAUSE OF STEVENS-JOHNSON SYNDROME. Annals of Allergy, Asthma and Immunology 131 (Suppl. 1): S120-S121 abstr. M078, No. 5, Nov 2023. Available from: URL: 10.​1016/​j.​anai.​2023.​08.​359 [abstact]
Metadata
Title
Amoxicillin/Clindamycin/Cotrimoxazole
Stevens-Johnson syndrome
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55061-5

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Pazopanib

Case report

Ocrelizumab

Case report

Multiple drugs

Case report

Tozinameran